Verve Therapeutics Shares Tumble After FDA Hold On Trial For Elevated Cholesterol Level Candidate
The FDA has instituted a clinical hold on Verve Therapeutics Inc’s (NASDAQ:VERV) IND application to conduct a clinical trial evaluating VERVE-101 in…